CDEK
← All drugs Report issue

sct-i10

mAbexperimental

Clinical trial activity

7 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
3
Phase 3
3
Phase 4
0

Earliest trial started Dec 13, 2018 (NCT03821363)

Timeline

2010s

  1. Jan 1, 2018

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2019

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2019

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05552807Phase 1Jun 15, 2022Huazhong University of Science and Technology, Sinocelltech Ltd.
NCT04560894Phase 2/Phase 3 (Phase 3)Nov 11, 2020Sinocelltech Ltd.
NCT04229537Phase 1Mar 1, 2020Sinocelltech Ltd., Tianjin Medical University
NCT04146402Phase 3Nov 8, 2019Chinese Academy of Medical Sciences, Sinocelltech Ltd.
NCT04146181Phase 2Oct 31, 2019Chinese Academy of Medical Sciences, Sinocelltech Ltd.
NCT04171284Phase 3Oct 22, 2019Jiao Tong University, Sinocelltech Ltd.
NCT03821363Phase 1Dec 13, 2018Sinocelltech Ltd.
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Sinocelltech Ltd.For profit7732018
Chinese Academy of Medical SciencesAcademic/Hospital2022019
Huazhong University of Science and TechnologyAcademic/Hospital1012022
Jiao Tong UniversityAcademic/Hospital1012019
Tianjin Medical UniversityAcademic/Hospital1012020
5 organizations
Page 1 / 1